Mangalam Drugs And Organics Ltd. benchmarking: Perfomance to industry peers

Financial

	Mangalam Drugs&Org.	Lasa Supergenerics	Bal Pharma
Operational Metrics
Unclassified
Advertisement Spend as a % of Total Sales	0.5 %	n/a	n/a
R&D as a % of Total Sales	3.31 %	n/a	1.06 %
Financials
5 yr Average ROE	-0.44 %	-8.32 %	8.41 %
5yr average Equity Multiplier	2.43	1.44	4.51
5yr Average Asset Turnover Ratio	1.0	0.77	1.01
5yr Avg Net Profit Margin	0.0	-8.22 %	1.86 %
Price to Book	0.31	0.87	1.49
P/E	0.0	0.0	17.15
5yr Avg Cash Conversion Cycle	17.41 Days	11.27 Days	27.6 Days
Inventory Days	132.58 Days	46.83 Days	99.82 Days
Days Receivable	38.43 Days	10.61 Days	115.65 Days
Days Payable	126.53 Days	83.41 Days	154.91 Days
5yr Average Interest Coverage Ratio	0.9	-18.91	1.5
5yr Avg ROCE	6.92 %	1.03 %	19.2 %
5yr Avg Operating Profit Margin	7.63 %	9.99 %	9.12 %
5 yr average Debt to Equity	0.59	0.2	1.95
5yr CAGR Net Profit	39.54 %	n/a	8.78 %
5yr Average Return on Assets	-0.18 %	-5.59 %	1.88 %
Shareholdings
Promoter Holding	50.3 %	53.65 %	50.86 %
Share Pledged by Promoters	34.58 %	20.66 %	0.0
Change in Promoter Holding (3 Yrs)	-0.12 %	9.87 %	-1.14 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Mangalam Drugs&Org.	Lasa Supergenerics	Bal Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Formulations 0 API 0	-	Product Wise Break-Up Pharmaceutical 0 Formulations 52.96 Active Pharmaceutical Ingredient (API) 43.44 Others 3.6
Location Wise Break-Up	Location Wise Break-Up Domestic 62.61 International 37.39 India 0 Rest of the World 0	Location Wise Break-Up International 0 Domestic 0 India 95.82 Rest of the World 0 Others 4.18	Location Wise Break-Up International 0 Domestic 0 India 36.5 Rest of the World 60.58 Others 2.92
Raw Material Break-Up	Raw Material Break-Up Artimesinin 61.91 Lumefantrine-3 26.55 Ethyl Acetate 2.91 EMME 2.42 PMPA 0 Others 6.21	-	-